| Primary |
| Drug Use For Unknown Indication |
46.6% |
| Product Used For Unknown Indication |
15.6% |
| Hypertension |
8.5% |
| Atrial Fibrillation |
6.0% |
| Chronic Obstructive Pulmonary Disease |
5.1% |
| Supraventricular Tachycardia |
2.2% |
| Cardiac Disorder |
1.7% |
| Osteoporosis |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
| Dermatitis |
1.3% |
| Epilepsy |
1.3% |
| Grand Mal Convulsion |
1.3% |
| Sedation |
1.3% |
| Suicidal Ideation |
1.1% |
| Arrhythmia |
1.0% |
| Prophylaxis |
1.0% |
| Alcohol Withdrawal Syndrome |
0.8% |
| Mucous Membrane Disorder |
0.8% |
| Tachycardia Paroxysmal |
0.8% |
| Essential Hypertension |
0.7% |
|
| Completed Suicide |
27.5% |
| Overdose |
7.3% |
| Toxic Epidermal Necrolysis |
7.3% |
| Vomiting |
7.3% |
| Syncope |
6.4% |
| Hypotension |
4.6% |
| Intentional Overdose |
4.6% |
| Renal Failure |
4.6% |
| Shock |
4.6% |
| Off Label Use |
3.7% |
| Drug Interaction |
2.8% |
| Oropharyngeal Swelling |
2.8% |
| Renal Failure Acute |
2.8% |
| Suicide Attempt |
2.8% |
| Cytolytic Hepatitis |
1.8% |
| Death |
1.8% |
| Headache |
1.8% |
| Nausea |
1.8% |
| Nodal Arrhythmia |
1.8% |
| Pharmaceutical Product Complaint |
1.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
24.8% |
| Product Used For Unknown Indication |
24.8% |
| Hypertension |
13.9% |
| Epilepsy |
3.6% |
| Hypertrophic Cardiomyopathy |
3.6% |
| Atrial Fibrillation |
2.9% |
| Cardiac Disorder |
2.9% |
| Prophylaxis |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Dermatitis |
2.2% |
| Grand Mal Convulsion |
2.2% |
| Supraventricular Tachycardia |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Arrhythmia |
1.5% |
| Migraine |
1.5% |
| Psoriatic Arthropathy |
1.5% |
| Renal Failure |
1.5% |
| Tachycardia Paroxysmal |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Asthma |
0.7% |
|
| Oedema |
8.7% |
| Renal Failure |
8.7% |
| Urticaria |
8.7% |
| Abdominal Pain Upper |
4.3% |
| Cytolytic Hepatitis |
4.3% |
| Drug Hypersensitivity |
4.3% |
| Dyspnoea |
4.3% |
| Haematoma |
4.3% |
| Hypotension |
4.3% |
| Iron Deficiency Anaemia |
4.3% |
| Photophobia |
4.3% |
| Pleural Effusion |
4.3% |
| Pneumonia |
4.3% |
| Pneumonia Legionella |
4.3% |
| Poisoning |
4.3% |
| Reperfusion Arrhythmia |
4.3% |
| Shock |
4.3% |
| Shoulder Operation |
4.3% |
| Sputum Purulent |
4.3% |
| Toxic Epidermal Necrolysis |
4.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.8% |
| Hypertension |
12.9% |
| Product Used For Unknown Indication |
10.0% |
| Back Pain |
7.5% |
| Atrial Fibrillation |
7.1% |
| Diabetes Mellitus |
5.7% |
| Rheumatoid Arthritis |
3.6% |
| Depression |
3.2% |
| Dyslipidaemia |
3.2% |
| Arteriosclerosis Coronary Artery |
2.9% |
| Asthma |
2.5% |
| Essential Tremor |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Osteoporosis |
2.1% |
| Malignant Melanoma |
1.8% |
| Pain |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Antibiotic Therapy |
1.1% |
| Cluster Headache |
1.1% |
| Hypersensitivity |
1.1% |
|
| Pneumonia |
12.8% |
| Cytolytic Hepatitis |
10.3% |
| Blood Pressure Inadequately Controlled |
7.7% |
| Dehydration |
5.1% |
| Dyspnoea |
5.1% |
| Femur Fracture |
5.1% |
| Hip Fracture |
5.1% |
| Hypoprothrombinaemia |
5.1% |
| Iron Deficiency Anaemia |
5.1% |
| Lactic Acidosis |
5.1% |
| Multi-organ Failure |
5.1% |
| Phlebitis |
5.1% |
| Transaminases Increased |
5.1% |
| Acute Coronary Syndrome |
2.6% |
| Aspartate Aminotransferase Increased |
2.6% |
| Back Pain |
2.6% |
| Balance Disorder |
2.6% |
| Blood Creatinine Increased |
2.6% |
| Cardiac Arrest |
2.6% |
| Cardiac Failure |
2.6% |
|
| Interacting |
| Arrhythmia |
50.0% |
| Hypertension |
25.0% |
| Lung Neoplasm Malignant |
25.0% |
|
| Cytolytic Hepatitis |
57.1% |
| No Adverse Event |
28.6% |
| Cardiac Failure |
14.3% |
|
